Foster Dykema Cabot & CO Inc Abbott Laboratories Transaction History

Foster Dykema Cabot & CO Inc

$827 Million
Q3 2023

A detailed history of Foster Dykema Cabot & CO Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Foster Dykema Cabot & CO Inc holds 3,272 shares of ABT stock, worth $370,946. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,272

Previous 3,403 3.85%

Holding current value

$370,946

Previous $371,000 14.56%

% of portfolio

0.04%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $12,514 - $15,015	-131 Reduced 3.85%	3,272 $317,000
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $5,039 - $5,614	-50 Reduced 1.45%	3,403 $371,000
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $24,118 - $28,388	249 Added 7.77%	3,453 $350,000
Q4 2022 Feb 01, 2023	SELL	$95.06 - $111.52 $85,554 - $100,368	-900 Reduced 21.93%	3,204 $352,000
Q3 2022 Feb 03, 2023	BUY	$96.76 - $112.03 $87,084 - $100,827	900 Added 28.09%	4,104 $397,000
Q2 2022 Jul 15, 2022	SELL	$102.07 - $123.37 $10,002 - $12,090	-98 Reduced 2.33%	4,104 $446,000
Q1 2022 May 10, 2022	SELL	$114.02 - $139.04 $23,374 - $28,503	-205 Reduced 4.65%	4,202 $497,000
Q3 2021 Oct 25, 2021	SELL	$116.66 - $129.06 $27,531 - $30,458	-236 Reduced 5.08%	4,407 $521,000
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $46,230 - $54,419	-437 Reduced 8.6%	4,643 $538,000
Q1 2021 May 03, 2021	SELL	$108.84 - $128.23 $33,958 - $40,007	-312 Reduced 5.79%	5,080 $609,000
Q4 2020 Feb 03, 2021	SELL	$105.0 - $114.42 $112,665 - $122,772	-1,073 Reduced 16.6%	5,392 $590,000
Q3 2020 Nov 06, 2020	BUY	$91.64 - $111.29 $5,590 - $6,788	61 Added 0.95%	6,465 $704,000
Q2 2020 Aug 05, 2020	SELL	$76.57 - $98.0 $1,301 - $1,666	-17 Reduced 0.26%	6,404 $586,000
Q4 2019 Feb 04, 2020	SELL	$78.51 - $87.4 $387,839 - $431,756	-4,940 Reduced 43.48%	6,421 $558,000
Q2 2019 Aug 06, 2019	SELL	$72.88 - $85.0 $2,623 - $3,060	-36 Reduced 0.32%	11,361 $955,000
Q1 2019 May 09, 2019	SELL	$66.22 - $80.06 $6,688 - $8,086	-101 Reduced 0.88%	11,397 $911,000
Q3 2018 Nov 02, 2018	SELL	$60.81 - $73.36 $2,249 - $2,714	-37 Reduced 0.32%	11,498 $843,000
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $51,205 - $57,894	-910 Reduced 7.31%	11,535 $691,000
Q4 2017 Jan 31, 2018	SELL	$53.68 - $57.47 $8,588 - $9,195	-160 Reduced 1.27%	12,445 $710,000
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $605,796 - $676,132	12,605	12,605 $673,000

Others Institutions Holding ABT

# of Institutions

3,167

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Dykema Cabot & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster Dykema Cabot & CO Inc with notifications on news.

Account

Foster Dykema Cabot & CO Inc Abbott Laboratories Transaction History